Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF-1 axis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF-1 axis

Published:2013-01-15 Issue:7 Volume:60 Page:1148-1153
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Narayanan Karthik R.,Bansal Deepak,Walia Rama,Sachdeva Naresh,Bhansali Anil,Varma Neelam,Marwaha R.K.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.24397/fullpdf

Reference27 articles.

1. Imatinib mesylate in Philadelphia chromosome-positive leukemia of childhood;Kolb;Cancer,2003

2. How I treat childhood CML;Andolina;Blood,2012

3. Imatinib mesylate in children and adolescents with cancer;Barr;Pediatr Blood Cancer,2010

4. Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: Results of the French national phase IV trial;Millot;J Clin Oncol,2011

5. Distinct impact of imatinib on growth at prepubertal and pubertal ages of children with chronic myeloid leukemia;Shima;J Pediatr,2011

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Tyrosine Kinase Inhibitors (TKIs) on Growth in Children and Adolescents with Chronic Myeloid Leukemia: A Systematic Review;Current Pharmaceutical Design;2024-09

2. Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I‐BFM Study Group;British Journal of Haematology;2024-05-27

3. BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach;Current Oncology Reports;2024-02-10

4. Endocrine late effects in childhood cancer survivors;Reference Module in Biomedical Sciences;2024

5. Treatment and follow‐up of children with chronic myeloid leukaemia in chronic phase (CML‐CP) in the tyrosine kinase inhibitor (TKI) era—Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohort;British Journal of Haematology;2023-12-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3